2010
DOI: 10.4065/mcp.2009.0778
|View full text |Cite
|
Sign up to set email alerts
|

A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of Armodafinil for Excessive Sleepiness Associated With Jet Lag Disorder

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
29
1
1

Year Published

2010
2010
2021
2021

Publication Types

Select...
5
4
1

Relationship

1
9

Authors

Journals

citations
Cited by 51 publications
(31 citation statements)
references
References 23 publications
0
29
1
1
Order By: Relevance
“…Armodafinil at a dose of 150 mg per day increased wakefulness after simulated eastbound travel through 6 time zones in 143 participants, compared with 142 controls, and was generally well tolerated. 31 …”
Section: Modafinilmentioning
confidence: 97%
“…Armodafinil at a dose of 150 mg per day increased wakefulness after simulated eastbound travel through 6 time zones in 143 participants, compared with 142 controls, and was generally well tolerated. 31 …”
Section: Modafinilmentioning
confidence: 97%
“…[15][16][17][59][60][61] Lack of a response to both objective and subjective measures has several possible explanations. The study may have been underpowered given the inter-individual variability in sensitivity to sleepiness seen in OSA patients (for given degrees of sleep apnea severity) and experimental sleep deprivation.…”
Section: Discussionmentioning
confidence: 99%
“…In the intestinal epithelium, they play a fundamental role hindering the invasion of tissues by pathogens (Bonazzi and Cossart, 2011). Furthermore, TJs are key components of the integrity of the blood-brain barrier, essential to avoid neurological dysfunction (Rosenberg et al, 2011).…”
Section: Introductionmentioning
confidence: 99%